Navigation Links
RBC Life Sciences and MPM Medical Inc. Donate 100,000 Sterile Wound Care Dressings to Help Haitian Earthquake Survivors
Date:2/3/2010

IRVING, Texas, Feb. 3 /PRNewswire-FirstCall/ -- RBC Life Sciences (OTC Bulletin Board: RBCL), a provider of proprietary nutritional supplements, wound care and pain management products, has donated 100,000 sterile dressings to help the tens of thousands of Haitian earthquake victims suffering from burns, abrasions, deep wounds and similar injuries.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100203/DA48340)

"Cleaning and properly treating wounds is critical following such a devastating tragedy," said RBC Life Sciences President and CEO John W. Price. "Infected or exposed wounds can trigger life-threatening problems. We're happy to join the global wound care community in providing the care that so many of the survivors need."

Under its MPM Medical brand, RBC Life Sciences specializes in wound care and pain management products. MPM Medical donated 100,000 of its Multilayered Composite Dressings to the Red Cross to be distributed by healthcare professionals on the island nation. Sterile wound care dressings are among the supplies needed to treat the most prevalent wounds suffered during the earthquake.

About RBC Life Sciences
RBC Life Sciences develops, manufactures and markets high quality nutritional supplements and personal care products to a growing population of consumers seeking wellness and a healthy lifestyle. Under its MPM Medical brand, RBC Life Sciences also develops and markets to health care professionals in the United States proprietary prescription and nonprescription products for advanced wound care and pain management. All products are tested for quality assurance in-house, and by outside independent laboratories, to comply with regulations in the U.S. and in more than thirty countries in which the products are distributed. For more information, visit the RBC Life Sciences Web site at www.rbclifesciences.com and the MPM Medical Web site at www.mpmmedicalinc.com

The statements above, other than statements of historical fact, may be forward-looking. Actual events will be dependent upon a number of factors and risks including, but not limited to, changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.

SOURCE RBC Life Sciences, Inc.

RELATED LINKS
http://www.rbclifesciences.com
http://www.mpmmedicalinc.com

'/>"/>

SOURCE RBC Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sangamo BioSciences Announces Fourth Quarter and Full Year 2009 Conference Call and Webcast
2. Caliper Life Sciences Introduces Sciclone(R) G3 Liquid Handler
3. Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)
4. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
5. Biovista Inc. Named Top Innovator in Life Sciences
6. Advanced Life Sciences Restanza Shows 100% Survival in Tularemia Pivotal Animal Study
7. Fujirebio Diagnostics Named Life Sciences Company of the Year
8. New Executive Leadership and CEO Announced for BiPar Sciences
9. Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium
10. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
11. Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... 25, 2017 , ... Somnoware, a leading provider of digital ... module. Using this new feature, sleep physicians can now predict the likelihood of ... airway pressure (CPAP), oral, or other forms of sleep apnea therapy. The Somnoware ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, the ... CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet in ...
(Date:4/24/2017)... Salt Lake City, UT (PRWEB) , ... April 24, 2017 , ... ... in their efforts to encourage sustainability, innovate new strategies to reduce waste, and support ... all-natural herbal remedy provider. They look to nature to find solutions for health issues, ...
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, eyewear, ... the rarified air of pop and film stardom.(1) Not to be left out is ... smile. Grins now run the gamut from being encrusted with jewels and precious metals ...
Breaking Medicine News(10 mins):